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Abstract: Clinical analyses benefit world-wide from rapid and reliable diagnostics tests. 
New tests are sought with greatest demand not only for new analytes, but also to reduce 
costs, complexity and lengthy analysis times of current techniques. Among the myriad of 
possibilities available today to develop new test systems, amperometric biosensors are 
prominent players—best represented by the ubiquitous amperometric-based glucose 
sensors. Electrochemical approaches in general require little and often enough only simple 
hardware components, are rugged and yet provide low limits of detection. They thus offer 
many of the desirable attributes for point-of-care/point-of-need tests. This review focuses 
on investigating the important integration of sample preparation with (primarily 
electrochemical) biosensors. Sample clean up requirements, miniaturized sample preparation 
strategies, and their potential integration with sensors will be discussed, focusing on 
clinical sample analyses.  
Keywords: electrochemical sensor; microfluidic-based sample preparation; clinical  
sample analysis  
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1. Introduction to Biosensor 
Since the first biosensors were proposed and demonstrated by Clark and Lyons in 1962 [1],  
the idea behind biosensors has been explored in a wealth of variations and has been defined with 
specific criteria by international union of pure and applied chemistry (IUPAC) in 1999 [2]. The 
exquisite specificity and sensitivity of biological recognition elements including antibodies [3], 
oligonucleotides [4], enzymes [5], and cell receptors [6] transduced through physical and chemical 
strategies that are not limited to electrochemical, optical or mass-based means has led to amazing 
analytical systems. The electrochemical glucose biosensor based on Clark’s original concept is the best 
known, likely best studied, and surely commercially most successful biosensor to date [7,8]. As much 
as new sensing systems are being developed today, effort is also put toward the important aspect of 
integration of the detection system with an efficient and appropriate sample preparation strategy to 
deal with actual real-world samples. Here, great expectations are put toward miniaturized “total 
analysis systems” (microTAS) that hold the promise of integrating sample preparation and biosensing 
in one small chip, creating a portable device. 
Electrochemical biosensors lend themselves well to clinical analysis as demonstrated exemplary by 
successful glucose sensors, the iStat, and other chemical sensors for blood gas and ion analysis [9,10]. 
The low-tech hardware requirements and high sensitivity are two major advantages that lead to the 
abundance of electrochemical biosensors. Transduction principles seen in clinical analysis include 
primarily amperometry, cyclic voltammetry, and differential pulse voltammetry. In addition to these 
electrochemical sensors, clearly no shortage of detection principles and assay formats exists ranging 
from optical, to mass-based, and piezoelectric formats [11], each providing unique aspects that are 
advantageous for specific settings, relating to limits of detection, ease-of-use, costs, assay time  
and alike. 
The range of analytes relevant in clinical diagnostics that have been addressed by biosensors and 
bioanalytical systems (not limited to electrochemical transduction) is staggering [12], including cancer, 
genome analysis, autoimmune diseases, infectious diseases, and cardiac biomarkers. In the case of 
infectious disease applications, monitoring and diagnostics of pathogenic microorganisms has been 
described for a long list of analytes (Table 1) also including those analytes that are relevant to the food 
industry, water, and environmental applications [13]. Maybe not surprisingly, the typical common 
challenge of biosensors that are designed for application to real-world samples is the matrix of the 
specimens, which may likely interfere with the results or negatively affect the detection principle of 
the assay. In the case of clinical specimens, such as blood (whole blood, serum, or plasma), urine, 
saliva, stool, sputum, and tissue, this challenge of sample preparation for diagnostics has been 
described by J. Liao and his group recently [14]. How miniaturized biosensors solve these challenges 
will be addressed further along in this article.  
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Table 1. Summary of pathogenic organisms relevant to clinical diagnostics for which 
biosensors have been developed. 
Virus Bacteria Fungi 
VariolaV [15,16] 
ChikungunyaV [15,16] 
Eastern encephalitis V [15,16] 
Venezuelan encephalitis V [15,16] 
Western encephalitis V [15,16] 
Dengue V [15,16] 
Yellow fever V [15,16] 
Japanese encephalitis V [15,16] 
Russian spring-summer encephalitis V 
[15,16] 
Argentine hemorrhagic fever V [15,16] 
Lassa fever V [15,16] 
Lymphocyte choriomeningitis V [15,16] 
Bolivian hemorrhagic fever V [15,16] 
Crimean-Congo hemorrhagic fever V 
[15,16] 
Haantan (Korean hemorrhagic fever) V 
[15,16] 
Rift Valley fever V [15,16] 
Marburg V [15,16] 
Ebola V [15,16] 
Hepatitis (A, E) V [15–17] 
Norwalk V [18] 
Rickettsia prowazecki [15,16] 
Rickettsia rickettsi [15,16,19] 
Rickettsia tsutsugamushi [15,16] 
Bacillus anthracis [15,16,19] 
Francisella (Pasteurella)tularensis 
[15,16,19] 
Pasteurellapestis [15,16] 
Brucellamelitensis,  
B. suis [15,16,19] 
Coxiellaburnetti [15,16,19] 
Salmonella typhi [15–17,19] 
Salmonella paratyphi [15,16,19] 
Salmonella enteric [17] 
Shigelladysenteriae [19]. 
Vibrio cholerae [15–17,19] 
Corynebacterium diphtheria  
[15,16,19] 
Actinobacillus mallei [15,16] 
Pseudomonas aeruginosa [17] 
Pseudomonas pseudomallei [15,16] 
Mycobacterium tuberculosis 
[15,16,19] 
Burkholderiapseudomallei [17] 
Campylobacter jejuni [17,19] 
Clostridium botulinum [19] 
Escherichia coli-pathogenic [17,19] 
E. coli O157: H7 [18] 
Legionella spp. [17] 
Yersinia enterocolitica [17] 
Yersinia pestis [19] 
Treponemapallidum [19] 
Streptococcus pneumonia [19] 
Staphylococcus aureus [19] 
Listeria monocytogenes [18] 
Coccidioidesimmitis [15,16] 
Histoplasmacapsulatum [15,16] 
Nocardiaasteroides [15,16] 
2. Pairing (Electrochemical) Biosensors with Sample Preparation for Analyte Detection in 
Clinical Samples 
Significant effort has to be invested in the design of a biosensor so that it can be applied to actual 
real-world samples. It is well known and often described how matrix effects, non-specific binding and 
interferences will negatively affect a biosensor signal to the point that no qualitative or quantitative 
analysis is possible. Sensor surfaces are therefore typically protected via membranes, films or simple 
blocking layers of adsorbed molecules in order to prevent any of these interferences. Examples are the 
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polyethylene glycol modified membrane of glucose sensors that prevent components such as ascorbic 
acid and uric acid to reach the electrode surface and hence render the electrochemical transduction 
specific [20,21]. Also, in heterogeneous immunoassays, surfaces are blocked with polymers or 
proteins, such as polyvinylpyrrolidone [22,23], gelatin [22,24] casein [25,26], or bovine serum 
albumin [27,28], respectively. Hydrogels or similar films are often applied to not only immobilize the 
biorecognition element but also function as diffusion barrier for interferences from the matrix [29,30]. 
Table 2. Important criteria for sample preparation processes considerations for the 
development of electrochemical (micro) sensors.  
Criteria Specific to 
Electrochemical 
Sensors 
Examples 
Additional Important 
Criteria and Those 
Specific to Microfluidic 
Electrochemical Sensors 
Examples 
Removal of 
electrochemically active 
compounds  
In serum/plasma [31]: 
- Uric acid 
- Ascorbic acid  
- Dopamine 
- L-cysteine 
- Acetaminophen  
- Salicylic acid 
In urine [32]: 
- Urea 
- Tartaric acid  
- Citric acid 
- Glucose 
- Leucine 
- Proline 
- Tyrosine 
In saliva [33]: 
- Uric acid 
- Ascorbic acid 
Removal of particulate  
to avoid clogging of 
microchannels and 
microvalves [34] 
Blood cells may form aggregates 
clogging  the microchannels  
during separation of plasma  
from blood [35] 
Adjustment of  
ionic strength and 
temperature [36,37] 
- Variable ionic strength influence 
potentiometric, conductimetric and 
also voltammetric measurements. In 
addition, ionic strength and nature 
affects biological reactions [36] 
- Temperature affects the slope of 
the electrode response according to 
the Nernst equation [37] 
Reducing non specific 
absorption of 
hydrophobic material 
such as PDMS [38] 
Adsorption of fluorescence markers 
can cause a drift in the background 
fluorescence intensity [38] 
Removal of surface 
fouling compounds [39] 
Fouling cause by plasma proteins, 
lipids, and other biochemical 
components of the biological fluids 
[39]  
Removal of compounds 
interfering with the 
biorecognition or signal 
amplification 
mechanisms [40] 
PCR inhibitors in blood  
sample such as heme,  
hemoglobin, lactoferrin and 
immunoglobulin G [40] 
Adjustment of pH [41] A pH buffer can be used to reduce 
hydroxyl ion (OH−) effects that 
interfere ISE electrodes [41] 
Adjustment of pH [42]  Surface charge (Zeta potential) of 
the microchannels’ walls is 
generally a function of the pH thus, 
the electroosmotic pumping process 
can be enhanced or degraded by 
changes in pH [42] 
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However, coatings and blocking strategies cannot circumvent all negative sample matrix effects, 
including fouling of surfaces, interference with biorecognition reactions, clogging of fluid channels, 
etc., and sample preparation is hence of imminent importance. Different criteria apply for different 
transduction principle in order to avoid matrix-effects. For example, turbidity is a common problem for 
optical sensors, auto-fluorescence for any fluorescence-based system, non-specific adherence of any 
particle is a challenge for mass-based systems, and the avoidance of electrochemically active compounds 
is mandatory for electrochemical sensors. In Table 2 specific criteria for sample preparation processes 
are listed as they relate to applications of clinical sample analyses with electrochemical sensors and 
those when used in microfluidic systems.  
The most often applied sample preparation steps are summarized in Figure 1. Whenever possible, 
the sample is being diluted in order to shift the effect of interferences below a tolerable threshold, i.e., 
when blocking and protecting functionalities of the biosensor design can be effective against undesired 
matrix components. This has been demonstrated, for example with glucose analyzers, such as those 
developed by Yellow Springs Instrument Company (Yellow Springs, OH, USA). Glucose oxidase is 
immobilized between two membrane layers. The outer polycarbonate membrane retains the enzyme, 
allows glucose to pass, but prevents larger molecules from entering, thus reducing interferences. The 
inner membrane is gas selective and necessary for the selectivity of the sensor [43]. Another example 
is the multilayered membranes developed by Matsumoto et al., which are able to measure glucose 
concentrations in a high enough range so that no sample dilution is required. Furthermore, the sensor 
provides a rapid response, a wide measuring range, and practical immunity to interference species 
(ascorbic acid, uric acid, and p-acetaminophen) [44,45]. However dilution or thick protective layers 
are obviously only applicable, if the analyte is present at high enough concentrations. Instead, other, 
frequently used simple sample preparation procedures include centrifugation, filtration, precipitation 
and deproteinization.  
 
Figure 1. Summary of the most often applied macro-system sample preparation procedures 
for clinical samples. 
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Blood as clinical sample has the advantage that it is the most rich with respect to variety of relevant 
analytes, yet also has the disadvantage to be the most rich with respect to matrix complexity and 
viscosity [14]. It can be divided into three types of specimen for each of which many amperometric 
biosensors have been presented, i.e., whole blood [46,47], serum [48–58], and plasma [59–61]. For 
whole blood and plasma, dilution is the most frequently used sample preparation step and was, for example 
used for the analysis of Zn2+ [46], neuropathy target esterase [47], glucose [20], pyrazinamide [59], 
prostate specific antigen [60], and nitrite/nitrate [61].  
Similarly, also for serum samples, dilution is the most often utilized technique and is combined with 
additional processing steps, such as centrifugation for dopamine [48], uric acid [48], glucose [49], and 
immunoglobulin A [62] analysis; precipitation for dopamine [53] and biphenyl [58] analysis; 
deproteinization with acid and filtration for glucose [55] analysis. It is important to keep in mind, 
though, that in some instances, especially in single-use devices, biosensors are described that can deal 
with the complex blood matrix without sample pretreatment step such as shown for glucose where 
Nafion membranes are known to cut down the most prevalent interferences such as ascorbic and uric 
acid [63] and nucleic acids (miRNAs) [64]. 
In the case of urine samples, the wide range of pH values found in samples can be challenging [14]. 
In addition to pH adjustment, centrifugation and dilution are two of the most often used sample 
preparation techniques as described for analytes, such as pirazinamide [58], anti-malarial drug 
(Artesunate) [65], testosterone [66], homocysteine [67], nuclear matrix protein 22 [68], dopamine [69], 
and uric acid [70–72].  
Similar to blood, saliva samples suffer from an immense component complexity and variation of 
compositions. Here, filtration and dilution methods are for example utilized for lactate [73] and 
nitrite/nitrate [62] analysis, respectively. 
Challenges associated with stool samples are most prominently similar to those of other solid 
materials such as soil, and solid food samples, but also the presence of high concentrations of bile. 
Centrifugation or filtration is typically a must in order to remove particulates, especially when 
considering microfluidic sensor developments [74]. 
3. Recent Strategies of Miniaturized Sample Preparation and Their Comparison to  
Bench-Top Standards 
When miniaturizing biosensors for clinical analysis, requirements for and necessity of analyte 
isolation from the sample matrix remain of utmost importance, in fact, additional challenges are added 
(Table 2). Microfluidic-based sample preparation can be classified into two groups (Figure 2). Most 
simply put, microtechniques are developed that copy one-to-one those techniques found in the  
macro-system, alternatively micro-phenomena are exploited to produce the same sample preparation 
result.  The comparison of microtechniques with corresponding bench-top strategies (Table 3) can be 
done either by directly comparing performance characteristics or by comparing final limits of detection 
reported for the respective target or model analytes. In some cases, this comparison is straight forward 
based on published data, in other cases this is more challenging due to limited data available. This 
section provides a few case studies for these important comparative evaluations.  
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Figure 2. Summary of microfluidic-based sample preparation techniques that are classified 
into two groups: (1) those obtained by scaling down a macro-system and (2) utilization of 
micro-system phenomena.  
Table 3. Comparison between micro techniques to corresponding bench-top methods for 
sample preparation based on published data.  
On-Chip Sample 
Preparation Techniques 
Bench-Top 
Methods 
Comparison Result of On-Chip 
To the Bench-Top Method 
References 
Microfilter membrane 
(Paper-based) 
Centrifugation Comparable [75] 
Microfilter membrane 
(Parylene) 
Immunomagnetic 
separation 
Better [76] 
Magnetic bead-based 
separation 
ELISA Comparable [77] 
Lab-on-a-disc ELISA Comparable [78] 
Miniaturized bead-beating In-tube bead-beating Comparable [40] 
Inertial force-based Flow cytometry Comparable [79,80] 
Dielectrophoresis Centrifugation 
Comparable  
(for purity) 
[81] 
Zweifach-Fung bifurcation Centrifugation Worse [82] 
Pinched- flow fractionation Centrifugation Worse [83] 
Acoustic force-based Centrifugation Better [84] 
Diffusion-based (H-filter) Centrifugation Comparable [85] 
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With respect to microfluidic techniques that utilizing macro-principles, filtration is an excellent 
example, such as the filtration of red blood cell agglutination complexes via paper-based microfluidics 
in order to detect the target analyte present in the plasma [75]. Microfilters [86–88] have also been 
developed as the straightforward method for cell separation in micro-system. Alternatively, 
centrifugation has been realized using lab-on-a-disc for the separation of target cells [78]. Similarly, 
magnetic field separation is realized in micro-systems by bead-based analyte capture integrated with 
microfluidic systems [89,90]. Cell lysis techniques used in the macro-system have also been realized in 
micro devices, such as mechanical [40,91], thermal [92–94], chemical [95], and electrical lysis [96]. 
All of these techniques can reduce the volume of sample/reagent, which is the main advantage of the 
scaling down devices while keeping the scientific principle of the sample preparation step the same.  
Comparing their efficiency to standard bench-top methods has been described by some researchers. 
An excellent example is the use of microfilter membranes for cell separation or concentration in 
microdevices. Yang et al. [75] developed a paper-based microfilter membrane for the separation of 
plasma from whole blood with the purpose of plasma glucose determination using a glucose  
oxidase-based colorimetric assay. The researchers compared this sample preparation technique with 
the conventional centrifugation method (800 rcf, 15 min) and found a good correlation of the results 
for both techniques. Similarly, parylene microfilter membranes, which were developed by Lin et al. [76], 
were applied to the identification of circulating tumor cells (CTCs) in whole blood. This system was 
shown to achieve more than 90% recovery and in fact showed better CTC identification when 
compared with CellSearch, a bench-top immunomagnetic separation technique.  
Also for magnetic bead and centrifugal force principles, the scaling down resulted in comparable 
results. For example, a magnetic bead-based proximity ligation assay was developed in which 
magnetic field-enhanced separation of the target analyte from human plasma was performed [77]. The 
detection range of this micro-system was found to be at 5–100 pg/mL. This compared well with 
respect to the limit of detection of a bench-top ELISA (2.2–50,000 pg/mL) for TNF-quantification, but 
fell short with respect to the dynamic range achievable. Lee et al. [78] developed a disc-based assay 
for anti-HBs and HBsAg from whole blood utilizing centrifugal forces for fluid movements.  
Their “Lab-on-a-disc” technique demonstrated comparable limits of detection to a bench-top ELISA 
for both analytes.  
As final example, cell lysis [40] using a miniaturized magnetically actuated bead-beating system 
was compared to the standard in-tube bead beating lysis method. In both cases, centrifugation and  
RT-PCR followed the initial lysis step for the detection of respiratory pathogens in nasopharyngeal 
aspirates. No difference in lysis efficiency was found between the micro- and macro systems.  
The second strategy to realize sample preparation in a miniaturized system takes advantage of 
phenomena unique to microfluidic systems or utilizes those that are very easy to realize in the micro-world 
in comparison to the macro-system. For example, cell separation and concentration can be accomplished 
using hydrodynamic phenomena, such as the Zweifach-Fung bifurcation effect [97,98], inertial  
force-based cell separation [99–102], centrifugal-on-a-chip (Figure 3) [103], evaporation-induced dragging  
effect [104], hydrodynamic filtration [105,106], pinched flow fractionation [107,108], and diffusion-based 
cell separation by using H-filters [109]. Cell separation has also been demonstrated using active separation 
techniques such as electrokinetic strategies [110–113] and acoustic forces [84,114]. 
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Figure 3. Particle entry mechanism in laminar microvortices. (a) For a polydisperse 
particle solution injected into a device with a straight high aspect ratio channel leading into 
an expansion-contraction chamber we expect size-dependent entry into the laminar vortices 
created; (b, c) Particles are subjected to a shear gradient lift force, which directs particles 
toward the channel wall, and a wall effect lift force, directed toward the channel center, 
which leads to entrainment of particles at dynamic equilibrium positions, Xeq; (d) As focused 
particles enter the vortex chamber, the lift forces are decoupled due to the absence of a 
nearby wall, resulting in a dominate shear gradient lift force. Larger particles (red) 
experience larger lift forces and are able to migrate across fluid streamlines into the vortices 
while smaller particles (blue) follow fluid streamlines and flow out of the system [103] with 
permission of The Royal Society of Chemistry.  
From a microfluidic device development point of view, the use of “microfluidic phenomena” 
comparability of results is very important, as completely new parameters are applied in bench-top and 
microsystems. Following are a few interesting studies reported. For example, for the separation of 
cancer cells from whole blood, an inertial force-based method was developed [79] and compared with 
flow cytometry. The microdevice showed superb cancer cell recovery rates in whole blood of 99.1%, 
blood cell rejection ratio of 88.9%, and a throughput of 1.1 × 108 cells/min which is comparable to the 
commercial flow cytometry systems’ achieved throughput (~2.4 million cells/min) [115]. The  
same inertial force-based technique was also applied for neural cell separation from cell culture 
medium [80]. Here, a throughput of ~1 million cells/min was found to be comparable to the 
commercial macroscale flow cytometer with an 80% efficiency and high relative viability (>90%).  
When comparing dielectrophoresis with macro-system centrifugation for blood plasma separation [81], 
plasma yield of 15.6% ± 2.5% and purity efficiency of 94.2% ± 3.6% were found for dielectrophoresis 
and plasma yield of 95% and purity efficiency of 99% were found for the centrifugation technique. 
Blood plasma separation by other microfluidic-based methods was also studied. Plasma yield of 40% 
and purity efficiency of 53% were found for the development of blood plasma separation by using the 
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Zweifach-Fung effect [82] and 80% of erythrocyte separation efficiency was found for the 
development of a Pinched-flow fractionation [83] microdevice. In other cases, lipid particle separation 
from blood was investigated which are relevant for intra-operative blood wash applications [84]. Here, 
Petersson et al. utilized an acoustic force-based technique and removed more than 80% of the lipid 
particles from the blood while collecting ~70% of the erythrocytes (recovery). The researchers 
discussed the quality of the separation to be excellent and additionally avoid standard problems of 
macroscale wash steps based on centrifugation including hemolysis, discontinuity, and a demand for 
large volumes (~500 mL) of blood.  
The Yager research group [85] developed an H-filter diffusion-based technique for the separation of 
small molecular analytes (Phenytoin, 252 Da) from saliva samples. The H-filters were comparable to 
centrifugal techniques [85,116], which were used to extract the analyte from the remaining large 
molecular weight species in the filtered saliva sample. Specifically, the H-filter processed saliva 
sample retained 23% of the analyte with 97% and 92% reduction in glycoproteins and proteins, 
respectively. Furthermore, subsequent detection processes were improved as the H-filter processed 
sample caused significantly less fouling of biosensor surfaces.  
Gillers et al. [117] developed microfluidic-based DNA extraction from crude stool samples prior to 
PCR amplification. While no direct comparison to the bench-top DNA extraction method was 
provided, the authors could demonstrate that their on-chip method resulted in extract purity suitable for 
subsequent PCR.  
4. Conclusions 
Bioanalytical sensors and miniaturized sample preparation strategies have been described and 
successfully applied to a variety of clinical samples. We conclude that the combination of several of 
the miniaturized sample preparation assays are ideally suited for the integration with electrochemical 
detection strategies. For example, the above-described acoustic force-based technique used for the 
separation of lipid particles [84] can easily be combined with a simple miniaturized amperometric 
detection strategy [74]. Here, electrochemical sensors such as those using nanomaterials integrated 
with the screen-printed electrodes (SPE) surface for cardiac biomarkers [118,119] will benefit from 
such a sample preparation step as electrode fouling through lipid particles will be avoided. Similarly, 
the dielectrophoretic generation of plasma from blood samples [81] would mean that plasma tests 
performed for human health diagnosis and treatment can be performed by simply applying the finger 
tip’s whole blood sample onto the microfluidic device and waiting for the results (sample-to-answer 
concept) [120]. In addition, saliva samples can be prepared and analyzed within microdevices for the 
detection of antibodies to HIV, therapeutic drugs and steroids [121] if an H-filter diffusion-based 
separation technique is directly integrated on chip.  
Assay systems like these can overcome the greatest shortcoming of today’s bioanalytical detection 
systems and be developed into commercially viable diagnostic tests. They will be effective, simple and 
rugged self-contained assays for point-of-care and point-of-need testing that on the one hand integrate 
innovative and novel concepts and on the other hand rely on well-established concepts that can be 
trusted for clinical diagnostics.  
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